QIAGEN today announced the expansion of its cell and gene therapy (CGT) portfolio with an enhanced digital PCR (dPCR) workflow that now includes solutions for lentivirus-based applications, commonly ...

In a phase 3 trial, 81% of wounds treated with autologous cell sheet-based gene therapy showed ≥ 50% healing at 6 months, ...

A newly published study in the Journal of Medical Entomology provides critical insights into the emergence of babesiosis in ...

Nigeria, Kebbi and Yobe stand out in Nigeria for their high malaria prevalence, each facing unique challenges in their fight against the disease.

President of the Republic Sergio Mattarella visited Bsp Pharmaceutical this morning for the traditional appointment on the ...

Discover six hemophilia companies developing new treatments for the genetic bleeding disorder, from gene therapies to RNAi therapies.

The Enugu State Commissioner for Health, Emmanuel Obi has appealed to government at all levels, non-government organisations ...

Fold7 creative Philippa Baines’s own health struggles helped inspire her team to create an impactful, London marathon-themed ...

Patients are compared to each other using multivariate time series (MTS) data. Each ICU patient's stay is represented as a time series capturing medical interventions like mechanical ventilation, ...

InVitria, a leading developer of recombinant, chemically defined components for biomanufacturing, has announced the launch of Optibumin® 25, the first and only recombinant human serum albumin (rHSA) ...

According to World Health Organization (WHO) Global Malaria Report 2024, there were over 263 million people who suffered because of malaria and over 597,000 who died of it worldwide in 2023. These ...